Detalhe da pesquisa
1.
International Validation of the Erasmus Guillain-Barré Syndrome Respiratory Insufficiency Score.
Ann Neurol
; 91(4): 521-531, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106830
2.
Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome.
J Neurol Neurosurg Psychiatry
; 94(4): 300-308, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428088
3.
Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
Brain
; 144(11): 3392-3404, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34553216
4.
Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
J Peripher Nerv Syst
; 23(4): 210-215, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30151941
5.
Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain-Barré Syndrome.
Neurocrit Care
; 26(1): 6-13, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27538676
6.
Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
Brain
; 137(Pt 1): 33-43, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24163275
7.
Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome.
EBioMedicine
; 102: 105072, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518653
8.
High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.
Neurol Neuroimmunol Neuroinflamm
; 10(4)2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059469
9.
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.
Neurology
; 98(5): e518-e532, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937789
10.
Prediction of respiratory insufficiency in Guillain-Barré syndrome.
Ann Neurol
; 67(6): 781-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20517939
11.
Emerging drugs for Guillain-Barré syndrome.
Expert Opin Emerg Drugs
; 16(1): 105-20, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21352072
12.
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
Lancet Neurol
; 20(4): 275-283, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743237
13.
IVIG treatment and prognosis in Guillain-Barré syndrome.
J Clin Immunol
; 30 Suppl 1: S74-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20396937
14.
Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barré syndrome.
PLoS One
; 14(2): e0211404, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30785890
15.
IVIg-induced plasmablasts in patients with Guillain-Barré syndrome.
Ann Clin Transl Neurol
; 6(1): 129-143, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30656191
16.
Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.
JAMA Neurol
; 74(2): 189-196, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28027337
17.
Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.
Nat Rev Neurol
; 10(8): 469-82, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25023340
18.
Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.
PLoS One
; 8(12): e82337, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24358172
19.
Historical sources of basilar artery occlusion.
Neurology
; 76(17): 1520-3, 2011 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21519003